ArticleWorld journal of urology2023

5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data.

Francesco Del Giudice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.